In conclusion, our study demonstrates that apatinib inhibits VEGF-mediated cell migration and invasion of CCA cell lines, possibly by blocking VEGFR2-dependent RAF/MEK/ERK and PI3K/AKT pathways. This evidence concerns the gene MAP2K7 and cholangiocarcinoma.